BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14716183)

  • 1. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
    Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
    Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy following the Women's Health Initiative (WHI) study: perception of gynecologists in Brazil.
    Machado RB; Fernandes CE; Maia E; Melo NR; Baracat EC
    Minerva Ginecol; 2005 Oct; 57(5):563-8. PubMed ID: 16205602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM; Korenstein D; Halm EA
    Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
    Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
    Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone use and patient concerns after the findings of the Women's Health Initiative.
    Rolnick SJ; Kopher RA; DeFor TA; Kelley ME
    Menopause; 2005; 12(4):399-404. PubMed ID: 16037754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.